Our Executive Team
Patrick Jordan
Founder & Director
Patrick found both the World Orphan Drug Alliance and Vector Pharma (MENA/T) in 2019. Most of his career of over 20 years has been in international settings with Pfizer and Merck with a deep knowledge of Russia and the Middle East. Most recently Patrick set up the International expansion of a Rare Disease company. His expertise lies in operational management and market access. Patrick has managed teams as large as 700 employees, with a focus on managing the bottom line for well leveraged growth. Patrick was born and raised in Athens, Greece.
Lassaad Kilani
Founder & Director
Lassaad is the other brother in the duo of the two founders/owners of the Kilani Group. Founded in 1986, the Group has grown to be the biggest health and Beauty conglomerate in Tunisia. The Kilani group and its subsidiaries operate in Pharmaceuticals, Para pharmaceuticals, FMCG, medical devices and Beauty and dermo-cosmetic products. The group is active in marketing, distribution, manufacturing, and promotion. In recent years Kilani group has expanded beyond Tunisia into the rest of the Middle East and into French and Sub Saharan Africa. With the groups latest acquisition of Adwya, the Kilani Group is now one of the largest manufactures in Africa.
Rafik Kilani
Founder & Director
Rafik is one of the two founders/owners of the Kilani Group. Founded in 1986, the Group has grown to be the biggest health and Beauty conglomerate in Tunisia. The Kilani group and its subsidiaries operate in Pharmaceuticals, Para pharmaceuticals, FMCG, medical devices and Beauty and dermo-cosmetic products. The group is active in marketing, distribution, manufacturing, and promotion. In recent years Kilani group has expanded beyond Tunisia into the rest of the Middle East and into French and Sub Saharan Africa. With the groups latest acquisition of Adwya, the Kilani Group is now one of the largest manufactures in Africa.
Sara Masmoudi
Chairwoman
CV??
Sandra Lambert
CEO
Sandra has a 24-year track record of successful product launches and sales in African pharmaceuticals, vaccines and medical devices. She has deep experience in leading organizations’, expansion into new markets, local licensing and registration strategies. Sandra started her career at MSD and led their vaccine and institutional unit. After time with Novartis as Franchise Head Primary Care Southern Africa and with Merck KGAa as Regional Director South and East Africa, Sandra was appointed as Chief Commercial Officer for The Biologics and Vaccines Institute of South Africa. Most recently, Sandra spent three years as the Managing Director for South Africa and Southern Africa for Baxter International. Sandra is a Healthcare professional registered with the HPCSA and has an MBA from the University of the Witwatersrand.
Tarek Hamami
CBO
CV??